Addback of Donor CD45RA Depleted Cells
CD45RA Depleted Peripheral Stem Cell Addback for Patients at Risk for Viral or Fungal Infections Post TCRαβ/CD19 Depleted Hematopoietic Stem Cell Transplant
More Information
- Trial Status
- Accepting patients
- Enrollment
- 50 patients (estimated)
- Sponsors
- Children's Hospital of Philadelphia
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Donor Lymphocyte Infusion (DLI), T Cell, Radiation Therapy
- Trial Type
- Supportive
- Last Update
- 3 months ago
- SparkCures ID
- 1653
- NCT Identifier
- NCT03810196
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.